196 related articles for article (PubMed ID: 24290875)
1. Recognition of pharmaceutical prescriptions across the European Union: a comparison of five Member States' policies and practices.
Miguel LS; Augustin U; Busse R; Knai C; Rubert G; Sihvo S; Baeten R
Health Policy; 2014 Jun; 116(2-3):206-13. PubMed ID: 24290875
[TBL] [Abstract][Full Text] [Related]
2. What to do when presented with a prescription from another European country: insight from a qualitative study of pharmacists in England.
Knai C; Saliba V; Davies J; McKee M; Khoshaba B; Lago E; San Miguel L
Int J Pharm Pract; 2014 Apr; 22(2):112-8. PubMed ID: 23849254
[TBL] [Abstract][Full Text] [Related]
3. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].
Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR
J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183
[TBL] [Abstract][Full Text] [Related]
4. Restrictions on import of drugs for personal use within the European single market.
Mäkinen MM; Rautava PT; Forsström JJ
Eur J Public Health; 2002 Dec; 12(4):244-8. PubMed ID: 12506498
[TBL] [Abstract][Full Text] [Related]
5. Electronic prescriptions are slowly spreading in the European Union.
Mäkinen M; Rautava P; Forsström J; Aärimaa M
Telemed J E Health; 2011 Apr; 17(3):217-22. PubMed ID: 21375413
[TBL] [Abstract][Full Text] [Related]
6. [Health policy in the European Union: impact on the Spanish health system].
Guimarães L; Freire JM
Cad Saude Publica; 2007; 23 Suppl 2():S143-54. PubMed ID: 17625642
[TBL] [Abstract][Full Text] [Related]
7. A European survey on the possibilities and obstacles of electronic prescriptions in cross-border healthcare.
Mäkinen M; Forsström J; Aärimaa M; Rautava P
Telemed J E Health; 2006 Aug; 12(4):484-9. PubMed ID: 16942421
[TBL] [Abstract][Full Text] [Related]
8. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
9. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
10. Twentieth anniversary of the European Union health mandate: taking stock of perceived achievements, failures and missed opportunities - a qualitative study.
Rosenkötter N; Clemens T; Sørensen K; Brand H
BMC Public Health; 2013 Nov; 13():1074. PubMed ID: 24225055
[TBL] [Abstract][Full Text] [Related]
11. Obstacles to the recognition of medical prescriptions issued in one EU country and presented in another.
San Miguel L; Baeten R; Remmen R; Busse R; Gil J; Knai C; Mäkinen M; Rubert G; McKee M
Eur J Public Health; 2013 Dec; 23(6):972-4. PubMed ID: 23756646
[TBL] [Abstract][Full Text] [Related]
12. Nurse prescribing of medicines in Western European and Anglo-Saxon countries: a survey on forces, conditions and jurisdictional control.
Kroezen M; Francke AL; Groenewegen PP; van Dijk L
Int J Nurs Stud; 2012 Aug; 49(8):1002-12. PubMed ID: 22369921
[TBL] [Abstract][Full Text] [Related]
13. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
14. Pan-European survey of the topical ocular use of cyclosporine A.
Labbé A; Baudouin C; Ismail D; Amrane M; Garrigue JS; Leonardi A; Figueiredo FC; Van Setten G; Labetoulle M
J Fr Ophtalmol; 2017 Mar; 40(3):187-195. PubMed ID: 28318723
[TBL] [Abstract][Full Text] [Related]
15. The Global Health Policies of the EU and its Member States: A Common Vision?
Steurs L; Van de Pas R; Delputte S; Orbie J
Int J Health Policy Manag; 2018 May; 7(5):433-442. PubMed ID: 29764107
[TBL] [Abstract][Full Text] [Related]
16. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
17. Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965-2007: case Finland.
Koski SM; Laitinen-Parkkonen P; Airaksinen M
Int J Health Plann Manage; 2015; 30(3):260-75. PubMed ID: 24375722
[TBL] [Abstract][Full Text] [Related]
18. Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review.
Kingham R; Wheeler J
Food Drug Law J; 2009; 64(1):101-14. PubMed ID: 19998574
[TBL] [Abstract][Full Text] [Related]
19. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
[TBL] [Abstract][Full Text] [Related]
20. Operational rules for the implementation of INN prescribing.
Van Bever E; Wirtz VJ; Azermai M; De Loof G; Christiaens T; Nicolas L; Van Bortel L; Vander Stichele R
Int J Med Inform; 2014 Jan; 83(1):47-56. PubMed ID: 24168761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
